Partial protective effect of inactivated Japanese encephalitis vaccine on lethal West Nile virus infection in mice

Vaccine

Volumn 21, Issue 31, 2003, Pages 4514-4518

  Takasaki, Tomohiko ^a   Yabe, Sadao ^a   Nerome, Reiko ^a   Ito, Mikako ^a   Yamada, Ken Ichiro ^a   Kurane, Ichiro ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Flaviviridae; Japanese encephalitis virus; Vaccine; West Nile virus

Indexed keywords

CROSS REACTING ANTIBODY; ENCEPHALITIS VACCINE; INACTIVATED VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY DEPENDENT ENHANCEMENT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CROSS REACTION; EPIDEMIC ENCEPHALITIS; EXPERIMENTATION; FEMALE; INFECTION RESISTANCE; LETHALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; VACCINATION; WEST NILE FLAVIVIRUS;

EID: 0142169008     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00507-3     Document Type: Article

References (10)

1. Lanciotti R.S., Roehrig V.D., Smith J., Parker M., Steele K., Crise B.et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science. 286:1999;2333-2337.
2. Center for Disease Control and Prevention. Weekly update: West Nile virus activity, United States, 14-20 November 2001. MMWR 2001;50:1061-3.
3. CDC. Provisional surveillance summary of the West Nile virus epidemic, United States, January-November 2002. MMWR 200;251:1129-33.
4. Kurane I., Takasaki T. Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strain. Vaccine. 18:2000;33-35.
5. Goverdhan MK, Kurkarni AB, Guputa AK, Tupe CD, Rodrigues JJ. Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques. Acta Virol 1992.
6. Tesh R.B., Amelia P.A., Rosa T., Guzman H., Araujo T.P., Xiao S.Y. Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis. Emerg Infect Dis. 8:2002;245-251.
7. Kanesa-Thasan N., Putnak J.R., Mangiofico J.A., Saluzzo J.E., Ludwig G.V. Short report: absence of protective neutralizing antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines. Am J Trop Med Hyg. 66:2002;115-116.
8. Blackburn N.K., Thompson D.L., Jupp P.G. Antigenic relationship of West Nile strains by titre ratios calculated from cross-neutralization test results. Epidemiol. Infect. 99:1987;551-557.
9. Oya A. Japanese encephalitis vaccine. Acta Pediatr Jpn. 30:1988;175-184.
10. Monath T.P. Prospects for development of a vaccine against the West Nile virus. Ann N Y Acad Sci. 951:2001;1-12.